
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 February 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Rosacea in Patients with Ulcerative Colitis and Crohn's Disease: A Population-based Case-control Study”, Inflamm Bowel Dis, vol. 22, pp. 680-7, 2016.
, “Statin use and risk of glioma: population-based case-control analysis”, Eur J Epidemiol, vol. 31, pp. 947-52, 2016.
, “Type II diabetes mellitus and incident osteoarthritis of the hand: a population-based case-control analysis”, Osteoarthritis Cartilage, vol. 24, pp. 1535-40, 2016.
, “Use of cardiac glycosides and risk of glioma”, J Neurooncol, vol. 127, pp. 321-8, 2016.
, “Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma”, PLoS One, vol. 11, p. e0149293, 2016.
, “Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis”, CNS Drugs, vol. 29, pp. 591-603, 2015.
, “Association of hormone therapy and incident gout: population-based case-control study”, Menopause, vol. 22, pp. 1335-42, 2015.
, “Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis”, Drug Saf, vol. 38, pp. 909-19, 2015.
, “Epidemiology of multiple sclerosis: results from a large observational study in the UK”, J Neurol, vol. 262, pp. 2033-41, 2015.
, “No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study”, BMC Cancer, vol. 15, p. 719, 2015.
, “Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: A case-control analysis”, Int J Cancer, vol. 137, pp. 2424-31, 2015.
, “Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer”, Int J Cancer, vol. 137, pp. 144-53, 2015.
, “Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study”, Ann Med, vol. 47, pp. 492-8, 2015.
, “Poorly controlled type 2 diabetes mellitus is associated with a decreased risk of incident gout: a population-based case-control study”, Ann Rheum Dis, vol. 74, pp. 1651-8, 2015.
, “Previously diagnosed influenza infections and the risk of developing epilepsy”, Epidemiol Infect, vol. 143, pp. 2408-15, 2015.
, , “Antihypertensive drugs and the risk of incident rosacea”, Br J Dermatol, vol. 171, pp. 130-6, 2014.
, “The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea”, Br J Dermatol, vol. 170, pp. 878-83, 2014.
, “Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities”, Br J Cancer, vol. 111, pp. 203-6, 2014.
, “Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK–a nested case-control analysis”, Diabetes Obes Metab, vol. 16, pp. 801-11, 2014.
, “Malaria chemoprophylaxis regimens: a descriptive drug utilization study”, Travel Med Infect Dis, vol. 12, pp. 718-25, 2014.
, “Metformin and the risk of head and neck cancer: a case-control analysis”, Diabetes Obes Metab, vol. 16, pp. 1148-54, 2014.
, “Mortality of patients with multiple sclerosis: a cohort study in UK primary care”, J Neurol, vol. 261, pp. 1508-17, 2014.
, “Use of anti-malarial drugs and the risk of developing eye disorders”, Travel Med Infect Dis, vol. 12, pp. 40-7, 2014.
, “Use of diuretics and risk of incident gout: a population-based case-control study”, Arthritis Rheumatol, vol. 66, pp. 185-96, 2014.
, “Antidepressant use during early pregnancy and the risk of congenital anomalies”, Pharmacotherapy, vol. 33, pp. 693-700, 2013.
, “Antihypertensive drugs and the risk of congenital anomalies”, Pharmacotherapy, vol. 33, pp. 476-82, 2013.
, “Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders”, Travel Med Infect Dis, vol. 11, pp. 71-80, 2013.
, “Association of childhood attention-deficit/hyperactivity disorder with atopic diseases and skin infections? A matched case-control study using the General Practice Research Database”, Ann Allergy Asthma Immunol, vol. 111, pp. 102-106.e2, 2013.
, “Association of infant pneumococcal vaccination with pneumococcal pneumonia among mothers: a nested case-control study using the GPRD”, Vaccine, vol. 31, pp. 1590-6, 2013.
, “Asthma drugs and the risk of congenital anomalies”, Pharmacotherapy, vol. 33, pp. 363-8, 2013.
, “Case-control analysis on metformin and cancer of the esophagus”, Cancer Causes Control, vol. 24, pp. 1763-70, 2013.
, “Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK”, J Alzheimers Dis, vol. 35, pp. 565-73, 2013.
, “Metformin and the risk of endometrial cancer: a case-control analysis”, Gynecol Oncol, vol. 129, pp. 565-9, 2013.
, “Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom”, J Am Acad Dermatol, vol. 69, pp. 399-406, 2013.
, “The risk of adverse outcomes in association with use of testosterone products: a cohort study using the UK-based general practice research database”, Br J Clin Pharmacol, vol. 75, pp. 260-70, 2013.
, “Risk of colorectal cancer after initiation of orlistat: matched cohort study”, Bmj, vol. 347, p. f5039, 2013.
, “Risk of incident stroke in patients with Alzheimer disease or vascular dementia”, Neurology, vol. 81, pp. 910-9, 2013.
, “Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000-2010”, BMJ Open, vol. 3, p. e003424, 2013.
, “Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis”, Epilepsia, vol. 54, pp. 700-7, 2013.
, “Use of acid-suppressive drugs in pregnancy and the risk of childhood asthma: bidirectional crossover study using the general practice research database”, Drug Saf, vol. 36, pp. 1097-104, 2013.
, “Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: incidence, all-cause mortality and characteristics at diagnosis”, Respirology, vol. 17, pp. 861-8, 2012.
, “Incidence of the pneumoconioses in the United Kingdom general population between 1997 and 2008”, Respiration, vol. 84, pp. 200-6, 2012.
, “Metformin does not alter the risk of lung cancer: a case-control analysis”, Lung Cancer, vol. 78, pp. 133-7, 2012.
, “Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study”, J Am Geriatr Soc, vol. 60, pp. 916-21, 2012.
, “Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database”, Acta Orthop, vol. 83, pp. 653-60, 2012.
, “A study on the epidemiology of rosacea in the U.K”, Br J Dermatol, vol. 167, pp. 598-605, 2012.
, “Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis”, Am J Gastroenterol, vol. 107, pp. 620-6, 2012.
, “Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis”, Cancer Epidemiol Biomarkers Prev, vol. 21, pp. 280-6, 2012.
, “Diabetes mellitus and the risk of cholecystectomy”, Dig Liver Dis, vol. 43, pp. 742-7, 2011.
,